Literature DB >> 24610677

iTRAQ analysis of colorectal cancer cell lines suggests Drebrin (DBN1) is overexpressed during liver metastasis.

Qifeng Lin1, Hwee Tong Tan, Teck Kwang Lim, Avery Khoo, Kiat Hon Lim, Maxey C M Chung.   

Abstract

Colorectal cancer is currently the third in cancer incidence worldwide and the fourth most common cause of cancer deaths. Mortality in colorectal cancer is often ascribed to liver metastasis. In an effort to elucidate the proteins involved in colorectal cancer liver metastasis, we compared the proteome profiles of the human colon adenocarcinoma cell line HCT-116 with its metastatic derivative E1, using the iTRAQ labelling technology, coupled to 2D-LC and MALDI-TOF/TOF MS. A total of 547 proteins were identified, of which 31 of them were differentially expressed in the E1 cell line. Among these proteins, the differential expressions of translationally controlled tumour protein 1, A-kinase anchor protein 12 and Drebrin (DBN1) were validated using Western blot. In particular, DBN1, a protein not previously known to be involved in colorectal cancer metastasis, was found to be overexpressed in E1 as compared to HCT-116 cells. The overexpression of DBN1 was further validated using immunohistochemistry on colorectal cancer tissue sections with matched lymph node and liver metastasis tissues. DBN1 is currently believed to be involved in actin cytoskeleton reorganisation and suppresses actin filament cross-linking and bundling. Since actin reorganisation is an important process for tumour cell migration and invasion, DBN1 may have an important role during colorectal cancer metastasis.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Biomedicine; Colorectal cancer; Drebrin; Liver metastasis; iTRAQ

Mesh:

Substances:

Year:  2014        PMID: 24610677     DOI: 10.1002/pmic.201300462

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  10 in total

1.  [Longitudinal analysis of vaginal microbiota in women with recurrent vulvovaginal candidiasis].

Authors:  Xiao Ma; Hui-Hua Cai; Yan He; Hui-Min Zheng; Ling Kang; Hong-Wei Zhou; Mu-Biao Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

2.  Tumor size, stage and grade alterations of urinary peptidome in RCC.

Authors:  Clizia Chinello; Marta Cazzaniga; Gabriele De Sio; Andrew James Smith; Angelica Grasso; Bernardo Rocco; Stefano Signorini; Marco Grasso; Silvano Bosari; Italo Zoppis; Giancarlo Mauri; Fulvio Magni
Journal:  J Transl Med       Date:  2015-10-20       Impact factor: 5.531

Review 3.  Cofilin-1 and Other ADF/Cofilin Superfamily Members in Human Malignant Cells.

Authors:  Sergey Shishkin; Lidia Eremina; Natalya Pashintseva; Leonid Kovalev; Marina Kovaleva
Journal:  Int J Mol Sci       Date:  2016-12-22       Impact factor: 5.923

4.  The drebrin/EB3 pathway drives invasive activity in prostate cancer.

Authors:  A E Dart; D C Worth; G Muir; A Chandra; J D Morris; C McKee; C Verrill; R J Bryant; P R Gordon-Weeks
Journal:  Oncogene       Date:  2017-03-20       Impact factor: 9.867

5.  Prognostic values of a novel multi-mRNA signature for predicting relapse of cholangiocarcinoma.

Authors:  Han Guo; Jie Cai; Xuan Wang; Bingrui Wang; Fang Wang; Xiang Li; Xiaoye Qu; Xianming Kong; Yueqiu Gao; Hailong Wu; Xuehua Sun; Qiang Xia; Xiaoni Kong
Journal:  Int J Biol Sci       Date:  2020-01-16       Impact factor: 6.580

6.  TFAP2A Induced ITPKA Serves as an Oncogene and Interacts with DBN1 in Lung Adenocarcinoma.

Authors:  Zhou Guoren; Fan Zhaohui; Zhu Wei; Wang Mei; Wu Yuan; Shi Lin; Xu Xiaoyue; Zhang Xiaomei; Shen Bo
Journal:  Int J Biol Sci       Date:  2020-01-01       Impact factor: 6.580

7.  Coexpressed Genes That Promote the Infiltration of M2 Macrophages in Melanoma Can Evaluate the Prognosis and Immunotherapy Outcome.

Authors:  Kexin Yan; Yutao Wang; Yuxiu Lu; Zhangyong Yan
Journal:  J Immunol Res       Date:  2021-03-08       Impact factor: 4.818

8.  Upregulation of long noncoding RNA W42 promotes tumor development by binding with DBN1 in hepatocellular carcinoma.

Authors:  Guang-Lin Lei; Yan Niu; Si-Jie Cheng; Yuan-Yuan Li; Zhi-Fang Bai; Ling-Xiang Yu; Zhi-Xian Hong; Hu Liu; Hong-Hong Liu; Jin Yan; Yuan Gao; Shao-Geng Zhang; Zhu Chen; Rui-Sheng Li; Peng-Hui Yang
Journal:  World J Gastroenterol       Date:  2021-05-28       Impact factor: 5.742

9.  Integrated Analysis of Key Differentially Expressed Genes Identifies DBN1 as a Predictive Marker of Response to Endocrine Therapy in Luminal Breast Cancer.

Authors:  Lutfi H Alfarsi; Rokaya El Ansari; Brendah K Masisi; Ruth Parks; Omar J Mohammed; Ian O Ellis; Emad A Rakha; Andrew R Green
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

10.  Risk assessment model constructed by differentially expressed lncRNAs for the prognosis of glioma.

Authors:  Chenggong Hu; Yongfang Zhou; Chang Liu; Yan Kang
Journal:  Oncol Rep       Date:  2018-08-10       Impact factor: 3.906

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.